CRISPR-Mediated Non-Viral Site-Specific Gene Integration and Expression in T Cells: Protocol and Application for T-Cell Therapy
T cells engineered with chimeric antigen receptors (CARs) show great promise in the treatment of some cancers. Modifying T cells to express CARs generally relies on T-cell transduction using viral vectors carrying a transgene, resulting in semi-random DNA integration within the T-cell genome. While...
Main Authors: | Zelda Odé, Jose Condori, Nicolas Peterson, Sheng Zhou, Giedre Krenciute |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-06-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/6/1704 |
Similar Items
-
Increasing Gene Editing Efficiency via CRISPR/Cas9- or Cas12a-Mediated Knock-In in Primary Human T Cells
by: Natalia Kruglova, et al.
Published: (2024-01-01) -
Endogenous protein tagging in medaka using a simplified CRISPR/Cas9 knock-in approach
by: Ali Seleit, et al.
Published: (2021-12-01) -
Highly efficient generation of knock-in transgenic medaka by CRISPR/Cas9-mediated genome engineering
by: Ikuko Watakabe, et al.
Published: (2018-02-01) -
Current Strategies for Increasing Knock-In Efficiency in CRISPR/Cas9-Based Approaches
by: Andrés Felipe Leal, et al.
Published: (2024-02-01) -
Genome editing of pseudorabies virus in the CRISPR/Cas9 era: a mini-review
by: Hai-Ming Wang, et al.
Published: (2023-07-01)